Sort

Search

01/03/2025 The dogma has been challenged: Local recurrence does not affect survival after glans-sparing surgery for penile cancer
Elst, L, Miletic, M, Roussel, E, Verdijk, R, Alnajjar, H, Di Nardo, N, Perri, D, Kaur, A, Sirard, RB, Basile, G, Bandini, M, Lobo, J, Hatzichristodoulou, G, Salonia, A, Breda, A, Spiess, PE, Parnham, A, Falcone, M, Bozzini, G, Muneer, A, Watkin, N, Ayres, B, Brouwer, OR, Albersen, M. The dogma has been challenged: Local recurrence does not affect survival after glans-sparing surgery for penile cancer. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025 Multicenter outcome analysis of different sheath sizes for Flexible And Navigable suction ureteric access Sheath (FANS) ureteroscopy. An EAU Endourology collaboration with the global FANS study group
Kwok, JL, Somani, B, Sarica, K, Yuen, SKK, Zawadzki, M, Castellani, D, Persaud, S, Chai, C, Kamal, W, Tefik, T, Tursunkulo, AN, Soebhali, B, El Hajj, B, Ko, R, Fong, KY, Dragos, L, Tanidir, Y, Angerri, O, Traxer, O, Gauhar,. Multicenter outcome analysis of different sheath sizes for Flexible And Navigable suction ureteric access Sheath (FANS) ureteroscopy. An EAU Endourology collaboration with the global FANS study group. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025 Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS)
Fernández, CM, Sebio, A, Rincón, JO, Broto, JM, Benlloch, AM, Plaza, DM, Pousa, AL, Alegría, IG, Giuppi, M, Ballesteros, EC, Bernabeu, D, de Alava, E, Morales, CV. Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS). Clinical & Translational Oncology. 2025; 27(3)DOI:10.1007/s12094-024-03602-5. PMID:39158802. IF:2.500(Q3/6D).
01/03/2025 Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship
Fa-Binefa, M, Serra, J, Moya, E, Crusi, X, Gich-Saladich, I, Valera, M. Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship. Hip International. 2025; 35(2)DOI:10.1177/11207000241306004. PMID:39757970. IF:1.100(Q3/7D).